March 2023
1. ESMAIL A, Randall P, Oelofse S, Tomasicchio M, et al
   Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
   Nat Med. 2023 Mar 9. doi: 10.1038/s41591-023-02247.
   

   >> Share

   
   January 2023
2. MCKENNA L, Frick M, Angami K, Dubula V, et al
   The 1/4/6x24 campaign to cure tuberculosis quickly.
   Nat Med. 2023 Jan 10. doi: 10.1038/s41591-022-02136.
   

   >> Share

   
   
3. MUSVOSVI M, Huang H, Wang C, Xia Q, et al
   T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
   Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02110.
   

   >> Share

   
   
4. OGONGO P, Ernst JD
   Finding antigens for TB vaccines: the good, the bad and the useless.
   Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02123.
   

   >> Share

   
   November 2022
5. CARVALHO T
   A new class of antibiotics delivers promising trial results against tuberculosis.
   Nat Med. 2022 Nov 30. doi: 10.1038/d41591-022-00114.
   

   >> Share

   
   September 2022
6. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
   Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
   Nat Med. 2022;28:1913-1923.
   

   >> Share

   
   
7. SCHMIDT TSB, Li SS, Maistrenko OM, Akanni W, et al
   Drivers and determinants of strain dynamics following fecal microbiota transplantation.
   Nat Med. 2022;28:1902-1912.
   

   >> Share

   
   
8. ISLAM MT, Ross AG, Sleigh AC, Chowdhury F, et al
   A blueprint for eliminating cholera by 2030.
   Nat Med. 2022;28:1747-1749.
   

   >> Share

   
   January 2022
9. SINHA S, Rosin NL, Arora R, Labit E, et al
   Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
   Nat Med. 2022;28:201-211.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share